What happens when you take cbd with beta-blockers?
Beta-blockers (metoprolol, propranolol, carvedilol, bisoprolol, atenolol, nebivolol) are dose-titrated to a specific heart-rate and blood-pressure target. CBD can interact with them in two small, additive ways, but the size of the effect is modest and, for the enzyme part, still largely theoretical.
- Weak enzyme inhibition. CBD weakly inhibits CYP2D6, the liver enzyme that clears several common beta-blockers, including metoprolol, propranolol, and carvedilol. The well-established potent CYP2D6 inhibitors are drugs like fluoxetine, paroxetine, and bupropion; CBD sits well below them.
- A theoretical rise in drug level. If CYP2D6 is slowed, beta-blocker levels could in principle climb a little above the dose your prescriber titrated to. This is a plausible pharmacokinetic pathway, but it has not been confirmed in human studies, and no measured changes in beta-blocker levels have been demonstrated.
- A mild blood-pressure dip from CBD itself. In a randomized crossover study, a single dose of CBD modestly lowered blood pressure in healthy volunteers, especially under stress. This pharmacodynamic effect runs in the same direction as the beta-blocker, so the two can add up.
Why is this important?
Beta-blockers are titrated to a target. Anything that pushes pulse or pressure further down can tip a sensitive patient into bradycardia, postural hypotension, fatigue, dizziness, or lightheadedness on standing. In older adults, a fainting spell or a fall can lead to fractures and hospital admissions, so even a small additive effect is worth noticing.
People with heart failure on carvedilol or bisoprolol have limited cardiac reserve, so a slow pulse plus low pressure is less well tolerated. And those who take propranolol for performance anxiety or essential tremor may reach for CBD specifically to feel calmer, which is exactly the situation where two mild downward effects can combine.
It is also easy to miss: beta-blockers are not on the commonly circulated "CBD danger" lists, which tend to emphasize warfarin, antiepileptics, and immunosuppressants. That does not make this a severe interaction, but it does mean you may have to raise it yourself.
What should you do?
Before you change anything: tell your prescriber and pharmacist you want to use CBD, and make sure it is on your medication list. Bring the bottle so the product type and strength are clear. Ask whether your particular beta-blocker matters here, atenolol and bisoprolol rely less on CYP2D6 than metoprolol or propranolol, though bisoprolol still has partial CYP3A4 metabolism.
Every day, especially the first couple of weeks: start CBD at a low dose and check your resting pulse and blood pressure at roughly the same times each day. Note how you feel on standing. If you take CBD only occasionally, the night before a stressful event, the interaction is smaller; still stand up slowly the next morning and avoid driving until you feel normal.
If something changes: stop the CBD and contact your prescriber if you notice a new, unusually slow pulse, a blood-pressure reading clearly below your normal, dizziness on standing, near-fainting, fatigue, or cold hands and feet. Do not stop the beta-blocker on your own, especially if you take it for coronary disease or arrhythmia, since stopping abruptly can cause rebound tachycardia and angina. Review any dose decisions with your doctor or pharmacist.
Which specific products are affected?
Beta-blockers in common use include metoprolol (Lopressor, Toprol-XL), propranolol (Inderal), carvedilol (Coreg), bisoprolol (Zebeta, Cardicor), atenolol (Tenormin), nebivolol (Bystolic), labetalol (Trandate), and timolol (oral and as eye drops). Sotalol is a beta-blocker with additional class III antiarrhythmic and QT-prolongation considerations, so it deserves extra caution.
On the CBD side, the products that matter are the ones absorbed into the bloodstream: tinctures and oils, capsules, gummies, infused beverages, sprays, and prescription Epidiolex. Topical CBD creams and balms have very low systemic absorption and are generally not a concern for this interaction. Full-spectrum and broad-spectrum products that contain measurable THC add their own cardiovascular effects and can complicate beta-blocker titration further.
The science behind it
The evidence here is real but thin, and it points to a plausible-but-unproven interaction rather than a documented clinical problem.
CBD's own cardiovascular effect is the best-supported piece. In the Jadoon randomized, placebo-controlled crossover trial in healthy volunteers, a single dose of CBD modestly lowered blood pressure, particularly under stress (PMID 28614793). For the substrate side, the metoprolol entry in the NCBI Medical Genetics Summaries, a pharmacogenomics reference, establishes that metoprolol is cleared extensively by CYP2D6 and that reduced CYP2D6 activity raises its plasma levels substantially (NBK425389).
For the enzyme interaction itself, a narrative cardiovascular CBD review describes CBD as a weak CYP2D6 inhibitor and notes that metoprolol, carvedilol, and propranolol are CYP2D6 substrates, while explicitly calling the interaction theoretical with clinical significance undetermined (review). A cross-sectional analysis mapping CBD use against interacting medications reaches the same conclusion: these beta-blockers are moderate CYP2D6 substrates, but there are few in vivo studies and no proven changes in beta-blocker levels (PMC12608321).
Frequently Asked Questions
Is combining CBD with a beta-blocker dangerous?
For most people it is a low-to-moderate concern, not an emergency. The two effects are mild and additive. The sensible approach is to start low, monitor your pulse and blood pressure, and loop in your prescriber rather than to avoid the combination outright.
Does CBD strongly raise beta-blocker levels?
No. CBD is a weak CYP2D6 inhibitor, far below drugs like fluoxetine or paroxetine. A rise in beta-blocker level is biologically plausible but has not been measured in human studies.
Which beta-blockers are most relevant?
Metoprolol, propranolol, and carvedilol are the ones cleared mainly by CYP2D6. Atenolol and bisoprolol depend on it less, though bisoprolol still has some CYP3A4 metabolism.
What symptoms should make me stop and call my prescriber?
A new and unusually slow pulse, a blood-pressure reading clearly below your normal, dizziness on standing, near-fainting, unusual fatigue, or cold hands and feet.
Are CBD creams a problem?
Topical CBD has very low systemic absorption and is generally not a concern for this interaction. The oral and sublingual products are the ones that reach the bloodstream.
Can I just stop my beta-blocker if I feel off?
No. Stopping a beta-blocker abruptly can cause rebound tachycardia and angina, especially in coronary disease or arrhythmia. Stop the CBD instead and talk to your prescriber about the beta-blocker.
Key takeaways
- CBD is a weak CYP2D6 inhibitor; any rise in beta-blocker levels is theoretical and unproven in humans.
- CBD also mildly lowers blood pressure on its own, so the two effects can add up in the same direction.
- Metoprolol, propranolol, and carvedilol are the most relevant beta-blockers; atenolol and bisoprolol rely on CYP2D6 less.
- Start CBD low, watch your pulse and blood pressure for a couple of weeks, and report new slow pulse, dizziness, or fainting.
- Never stop a beta-blocker abruptly; stop the CBD and review the plan with your doctor or pharmacist.